The effect of s ubcutaneously administered 13-cis-retinoic acid and an aromatic retinoid (Ro 10-9359) on the sebaceou s glands of th.e hamster flank organ were compared. As previously reported, 13-cis-retinoic acid caused a marked diminution of sebaceous gland size without affecting other androgen d ependent structures. The aromatic retinoid derivative showed no effect upon any of the flank organ components. Studies utilizing androgen stimulated female confirmed our previous finding that 13-cis-retinoic acid prevented the growth of sebaceous glands without affecting the development of dermal pigme ntation or la rge pigmented hair follicles. The aromatic retinoid derivative showed slight, if any, effect upon sebaceou s gland size and no effect upon pigmentation or pigmented follicle development. The findings with this model system suggest that any efficacy of Ro 10-9359 in the treatment of acne would be by some mode other than the inhibition of sebum production.
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Two retinoids, 13-cis-retinoic acid and a n aromatic retinoid derivative (Ro 10-9359) have been reported to be effi cacious in disorders of epidermal keratinization [1, 2] . 13-cis-Retinoic acid has also been reported to be extremely effective in t he treatment of severe cystic acne [3] a nd appears to exert its effect in t his condition by the mal' ked suppression of sebum production [3, 4] ' 13-cis-Retinoic acid has also been shown to cause marked atroph y of the sebaceous gland but not the other androgen dependent structures of the hamster flank organ [5] , a tissue that has proved useful for assaying potency of drugs, such as antia ndrogens, which affect sebaceous gla nd growth [6] [7] [8] [9] . We have compared the effectiveness of 13-cis-retinoic acid and an aromatic retinoid (Ro 10-9359) in producing sebaceous gland atroph y in th e hamster think organ in t he hope t hat t his assay might prove predictive of efficacy in the treatment of ac ne.
MATERIALS AND' METHODS
Mature male Syrian hamsters purchased and caged as previously described [5) were injected subcutaneously with 13-cis-retinoic acid, the aromatic retinoid, or the vehicle. Both the 13-cis-retinoic acid and the aromatic retinoid were a gift of Hoffmann-La Roche, Inc., and were suppled as 25% concentrates in an oil vehicle (70.5% soybean oil, 0.8% beeswax, 0.8% hydrogenated soybean oil flakes, 19.4% vegetable shorteqing, 0.3% disodium Edetate and 0.07% butylated hydroxya nisole). The 13-cis-retinoic'acid concentrate was stored under nitrogen at -20 degrees centrigrade and the aromatic retinoid concentrate was stored in the dark at room tempera ture as per the directions of the Hoffmann-La Roc he Corporation'. Assay of the aromatic retinoid concentrate by the Hoffmann-La Roche Corp. two months after completion of the experiments showed that the material was indeed Ro 10-9359 and that there had been no loss in potency. Prior to injection, the 13-cis~retinoic acid concentrate was brought to room temperature by immersion of the bottle in water. The concentrates and the placebo oil were administered by subcutaneous injection at a site distant from the flank organs. Animals were injected twice each week for a period of 3 weeks. In experiments using females, 40 mg of testosterone enanthate was injected concurrently with the frrst administration of the retinoids or place bo. The testosterone injection was repeated weekly during the co urse of the experiment.
After 3 weeks of treatment, the animals were sacrificed and the fl ank organs removed and processed for histologic examination as previously described [5] .
RESULTS
S ubcuta neous administration of 13-cis-retinoic acid a nd Ro 10-9359 in an identical oil vehicle produced different results. Animals treated with 13-cis -retinoic acid showed a marked inhibition of sebaceo us gland size as previously d escribed [5] . Administration of Ro 10-9359 produced no change in the size of th e flank organs sebaceous glands when compared to animals treated with the oil vehicle alone (Figure) .
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Experiments ut ilizing testosterone ena nthate stimulated females showed a marked inhibition by 13-cis-retinoic acid of the growth of the sebaceo us gla nds but not other a ndrogen depende nt struct ures of the hamster flank organ, as previously described [5] . T reatm ent of such a nima ls with Ro 10-9359 showed slightly less growt h of the sebaceous glands than did vehicle treated controls. The effect was slight a nd not noted in all animals.
DISCUSSION
Our recent studies with 13-cis-retinoic acid have de monstrated t hat the sebaceous gla nds of t he hamster flank organ may be a suitable assay for the effe ct of the retinoids upon sebaceous glands. It appears that this effect is not present in all biologically active retinoids since an aromatic retinoid derivative (Ro 10-9359) which has shown effic acy in t he treatm~nt of psoriasis and other keratinizing disorde rs has little effect upon sebaceous gland growth in this system. Our assay differs from the clinical use of the retinoids, which is by oral administration. Thus, release of the retinoid from the subcutaneously injected oil vehicle or a need for metabolism or activation of the compound in the process of a bsorption from t he gut may influence our results. 13-cis -Retinoic acid a ppeal's to present no difficulties in this regard. The lack of effect noted with Ro 10-9359 was not due to an inactive or incorrectly prepared formulation since subsequent a nalysis of the material used, performed by laboratories at Hoffman-LaRoche, confIrmed both t he identity and potency of the preparation.
We have found no published clinical reports concerning the efficacy of Ro 10-9359 in the treatment of acne or on sebum production. Our assay would predict that any effect of this compound in the treatment of acne would be by some mode other than the inhibition of sebum production.
